Data / Form D filings / Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc.: Form D filings
Aquyre Biosciences, Inc., a biotechnology company in Weston, MA, filed 6 Form D notices with the SEC between 2021 and 2023. The latest, on October 23, 2023, reports $3.2 million sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 133 BOSTON POST ROAD, Weston, MA, 02493
- Phone
- (774) 220-7040
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1887377
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | New notice | $10,000,000 | $3,220,502 | $6,779,498 | 2 | Sep 29, 2023 | sec.gov |
| May 27, 2022 | Amendment | $5,500,000 | $5,423,710 | $76,290 | 3 | Feb 25, 2022 | sec.gov |
| May 13, 2022 | Amendment | $5,000,000 | $4,999,995 | $5 | 3 | Feb 25, 2022 | sec.gov |
| Apr 14, 2022 | Amendment | $5,000,000 | $3,662,100 | $1,337,900 | 2 | Feb 25, 2022 | sec.gov |
| Mar 9, 2022 | New notice | $2,000,000 | $2,000,000 | 1 | Feb 25, 2022 | sec.gov | |
| Oct 13, 2021 | New notice | $37,997,973 | $19,945,190 | $18,052,783 | 71 | Sep 29, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cosme James Ordonez | Director | |
| Floyd Samuel Eberts, III | Executive Officer, Director | |
| Ronald James Sorenson | Director | |
| Claude Samuel Boccara | Executive Officer | |
| Richard Samuel McCann | Executive Officer | |
| Bertrand Samuel Le Conte Chrestien de Poly | Executive Officer, Director | |
| Gregory Samuel Bowles | Executive Officer | |
| Francois Samuel Grammont | Executive Officer | |
| Aurelio James Fernandez | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 23, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aquyre Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.